alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                          865553
<SECURITIES>                                         0
<RECEIVABLES>                                    46529
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                913056
<PP&E>                                        38998589
<DEPRECIATION>                                   19263
<TOTAL-ASSETS>                                41176556
<CURRENT-LIABILITIES>                           338952
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                    40043242
<TOTAL-LIABILITY-AND-EQUITY>                  41176556
<SALES>                                         609348
<TOTAL-REVENUES>                                740873
<CGS>                                           441975
<TOTAL-COSTS>                                    67858
<OTHER-EXPENSES>                                116613
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 114427
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             114427
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    114427
<EPS-PRIMARY>                                     2.29
<EPS-DILUTED>                                     2.29
        

</TABLE>
Exhibit 4.28


 


Execution Copy


 


[Note: Translation from the original written
in Chinese]


 


Power of Attorney


 


I, Guangfu Cui, a citizen
of the People’s Republic of China (“China”), hold a 87.5% equity interest in Beijing eLong Information
Co., Ltd. (the “Company”). I hereby irrevocably agree to authorize eLong, Inc., or any entity or person designated
in writing by eLong, Inc. (including such party’s successor), (the “Authorized Party”) to hold and exercise the
following rights related to this equity interest during the period of validity of this Power of Attorney:


 


Authorize the Authorized
Party to have full rights and authority to represent me, in my name as holder of 87.5% equity interest, according to law and the
company’s articles of incorporation, to exercise any and all shareholder rights, including but not limited to: the right
to convene shareholders’ meetings, receive any notices or procedures regarding shareholders’ meetings, to attend shareholders’
meetings and exercise full voting power as the holder of 87.5 equity interest (including, as my authorized representative, designating
or appointing the Company’s Directors, General Manager, Finance Controller and other senior management, determining dividends,
and other matters), to sell or transfer my 87.5% equity interest in the Company, etc.


 


The Authorized Party
has the right to designate its Directors (or Executive Director) to appoint a person to exercise the rights granted by this Power
of Attorney.


 


This Power of Attorney
shall become binding, effective and enforceable upon my signature. The Power of Attorney shall have a term of 20 years, which may
be automatically extended for successive additional 20 year terms without limit, as long as I remain a holder of any equity interest
in the Company.


 


[remainder of page intentionally left blank]


 




    	- 1 -



    	 



    

 


[Power of Attorney signature page]


 


	Authorizing Party :	 
	 	 
	Signature :  	  /s/Guangfu Cui	 
	 	 	 
	Date:  12/26/2012	 


 


	Authorized Party : 
	 
	eLong, Inc.
	 
	Signature of authorized representative :	 /s/Sami Farhad 	 
	 	 	 
	Date


 




    	- 2 -
Exhibit 31.1**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER**I, Douglas J. Cahill, President and Chief Executive Officer of Doane Pet Care Company, herebycertify that:1. I have reviewed this annual report on Form 10-K of Doane Pet Care Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: a) designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, ismade known to us by others within those entities, particularly during the period inwhich this report is being prepared;  b) evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this reportbased on such evaluation; and  c) disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter(the registrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of registrant’s board of directors (or persons performing the equivalentfunction): a) all significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize and reportfinancial information; and  b) any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control overfinancial reporting.        Date: March 30, 2006       /s/ DOUGLAS J. CAHILL   Douglas J. Cahill   President and Chief Executive Officer
fs1a10510ex10xvi_chinabct.htm


 



Exhibit 10.16


 


Liquid Capital Loan Agreement


 


Borrower (Party A): Guangxi Hefeng Pharmaceutical Co., Ltd.


Address: Donglan County, Third Development District


Legal Representative: Jin Hua Li


Address: Wuzhou, Guangxi


Creditor (Party B): Jin Hua Li







Due to its production and operation needs, Party A apply for a loan from Party B and Party B agrees to make a loan to Party A. To specify the parties’ rights and obligations and in accordance with Contract Law and other laws and regulations, Party A and Party B entered into this agreement after negotiation.







Article 1. The type of loan is Liquid Capital Loan.







Article 2. The usage of loan is to purchase raw materials.







Article 3. Loan amount is RMB 650,000. The term of the loan is 12 months, from 12/6/2006 to 12/5/2007.







Article 4. The loan interest is 0.68% per month. The interest shall be calculated daily from the date of withdrawal. The interest shall be paid monthly. The principle shall be paid on the expiry date of the loan.







Article 5. The source of the repayment fund shall be from the operation revenue.







Article 6. Rights and obligations of the parties:


 


1. Party A’s rights and obligations: (1) Withdraw and use the loan in accordance with this agreement. (2) Shall not repay the loan before the expiry date without Party B’s consent. (3) Voluntarily accept Party B’s investigation, study and monitor of the usage of the loan. (4) Repay the loan principle and interest in accordance with the terms in this agreement. (5) If Party A fails to repay the loan within the terms specified in this agreement, it shall be deemed Party A grants Party B an automatic loan extension.







2. Party B’s rights and obligations: (1) Party B has the right to demand Party A to repay the loan within any amount of time. (2) Party B has the right to demand Party A to provide any documents related to the loan. (3) Party B shall provide enough fund to Party A in accordance with the loan agreement.







Article 7 The agreement has two copies, each party holds one copy with equal legal effect.







Party A: Guangxi Hefeng Pharmaceutical Co., Ltd.


Legal Representative (Signature): /s/ Jin Hua Li







Party B: /s/ Jin Hua Li







Date: 12/6/2006
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection  with the Quarterly  report of Collectible  Concepts  Group,
Inc. (the  "Company") on Form 10-QSB for the period ending May 31, 2004 as filed
with the Securities and Exchange  Commission on the date hereof (the  "Report"),
I, Paul S. Lipschutz,  Chief Executive Officer of the Company, certify, pursuant
to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1)   The Report fully complies with the  requirements of section 13(a) or
            15(d) of the Securities and Exchange Act of 1934; and

      (2)   The  information  contained in the Report  fairly  presents,  in all
            material respects,  the financial condition and result of operations
            of the Company.

      A signed  original of this written  statement  required by Section 906 has
been  provided  to  Collectible  Concepts  Group,  Inc.  and will be retained by
Collectible  Concepts  Group,  Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.

Date:   April 14, 2005                      By: /s/ PAUL S. LIPSCHUTZ
                                              -----------------------
                                              Paul S. Lipschutz
                                              Chief Executive Officer
I 

111TH CONGRESS 

1ST SESSION H. R. 3860 

To suspend temporarily the duty on Propanenitrile, 3-[[4- 

[(substituted)azo]phenyl] (substituted)amino]-. 

IN THE HOUSE OF REPRESENTATIVES 

OCTOBER 20, 2009 

Mr. WATT introduced the following bill; which was referred to the Committee 

on Ways and Means 

A BILL 

To suspend temporarily the duty on Propanenitrile, 3-[[4- 

[(substituted)azo]phenyl] (substituted)amino]-. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. PROPANENITRILE, 3-[[4-[(SUB4 STITUTED)AZO]PHENYL] (SUB5 STITUTED)AMINO]-. 

6 (a) IN GENERAL.—Subchapter II of chapter 99 of 

7 the Harmonized Tariff Schedule of the United States is 

8 amended by inserting in numerical sequence the following 

9 new heading: 


srobinson on DSKHWCL6B1PROD with BILLS
2 

•HR 3860 IH

‘‘ 9902.01.00 Propanenitrile, 3-[[4-[(substituted)azo] 

phenyl](substituted)amino]-. 

(CAS No. P 99–539) (provided for in subheading 

2921.59.80) ........................... Free No change No change On or before 

12/31/2011 ’’. 

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to articles entered, or withdrawn 

3 from warehouse for consumption, on or after the 15th day 

4 after the date of the enactment of this Act. 

Æ 


srobinson on DSKHWCL6B1PROD with BILLS
IN THE COURT OF CRIMINAL APPEALS

OF TEXAS

NO. PD-0050-12

EX PARTE JESSICA TATA

ON DISCRETIONARY REVIEW

FROM THE FIRST COURT OF APPEALS

HARRIS COUNTY

Per curiam. Meyers, J., not participating.

The petition for discretionary review is dismissed as improvidently granted.

Delivered December 5, 2012.

Do not publish.
I 

111TH CONGRESS 

1ST SESSION H. R. 3951 

To designate the facility of the United States Postal Service located at 

2000 Louisiana Avenue in New Orleans, Louisiana, as the ‘‘Roy 

Rondeno, Sr. Post Office Building’’. 

IN THE HOUSE OF REPRESENTATIVES 

OCTOBER 28, 2009 

Mr. CAO (for himself, Mr. BOUSTANY, Mr. CASSIDY, Mr. MELANCON, Mr. 

FLEMING, Mr. ALEXANDER, and Mr. SCALISE) introduced the following 

bill; which was referred to the Committee on Oversight and Government 

Reform 

A BILL 

To designate the facility of the United States Postal Service 

located at 2000 Louisiana Avenue in New Orleans, Louisiana, as the ‘‘Roy Rondeno, Sr. Post Office Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. ROY RONDENO, SR. POST OFFICE BUILDING. 

4 (a) DESIGNATION.—The facility of the United States 

5 Postal Service located at 2000 Louisiana Avenue in New 

6 Orleans, Louisiana, shall be known and designated as the 

7 ‘‘Roy Rondeno, Sr. Post Office Building’’. 


srobinson on DSKHWCL6B1PROD with BILLS
2 

•HR 3951 IH

1 (b) REFERENCES.—Any reference in a law, map, reg2 ulation, document, paper, or other record of the United 

3 States to the facility referred to in subsection (a) shall 

4 be deemed to be a reference to the ‘‘Roy Rondeno, Sr. 

5 Post Office Building’’. 

Æ 


srobinson on DSKHWCL6B1PROD with BILLS
11TH COURT OF APPEALS

EASTLAND, TEXAS

JUDGMENT

Vernon Lee Willis Jr., * From the County Court

of Eastland County,

Trial Court No. 1700356.

Vs. No. 11-20-00083-CR * March 24, 2022

The State of Texas, * Memorandum Opinion by Williams, J.

(Panel consists of: Trotter, J.,

Williams, J., and Wright, S.C.J.,

 sitting by assignment)

(Bailey, C.J., not participating)

This court has inspected the record in this cause and concludes that there is 

error in the judgment below. Therefore, in accordance with this court’s opinion, 

the judgment of the trial court is reversed, and we render a judgment of acquittal.
10356

#### GALLIVAN v. PHŒNIX FIRE INS. CO.

(101 S. E. 927.)

1. Refusal to Direct a Verdict por Defendant.- — -Under all the evidence in this ease, the Judge was clearly right in submitting the issues to the jury for their determination.

2. Refusal to Grant a New Trial Upon the Ground That the Verdict *of*the Jury Was Not Sustained by the Evidence. — There was ample evidence to sustain the verdict.

3. Judge's Charge. — The Judge’s charge was lucid, fair and full.

Before Mauldin, J., Greenville, Summer term, 1919.

Affirmed.

Action by J. F. Gallivan against the Phoenix Fire Insurance Company. Judgment for plaintiff, and defendant appeals. Affirmed.

*Mr. K. K. T ozones,*for appellant

(no citations).

*Mr. L. K. Clyde*and *Messrs. Cothran, Dean & Cothran,*for respondent. *Mr. Clyde*

cites: *As to waiver:*57 S. C. 370; 94 S. C. 299; 97 S. C. 275; Code of Daws (1912), secs. 2711-2212; *Huestiss v. Ins. Co.,*31, 102 S. C. 227; 102 S. C. 313; 104 S. C. 403.

January 26, 1920.

The opinion of the Court was delivered by

Mr. Justice Watts.

*182This was an action for recovery of a policy of fire insurance, and was tried at the July term of Court, 1919, for Greenville county, before Judge Mauldin, and a jury, resulting in a verdict in favor of plaintiff. After entry of judgment, defendant appeals, and by eight exceptions alleges error and raises the following questions: Error in the Circuit Judge in not directing a verdict for the defendant, upon the evidence and provisions of the policy of insurance, and not sufficient evidence to sustain the verdict, and exceptions to the Judge’s charge to the jury.

We see no errors on the part of his Honor as made by the exceptions. Under all the evidence in the case he was clearly right in submitting the issues to the jury, as he did, for their determination, and there is ample evidence to sustain their verdict, and there was no error in his charge, whereby the appellant was prejudiced. His charge was lucid, fair, and full.

All exceptions are overruled, and judgment affirmed.
EXHIBIT 31.1

                         CERTIFICATION OF THE PRESIDENT

I, Michael Kelleher, President of Quantum Companies, Inc. certify that:


(1) I have reviewed this periodic report on Form 10-QSB of Quantum Companies,
Inc;

(2) Based on my knowledge, this periodic report does not contain any untrue
statements of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this periodic
report;

(3) Based on my knowledge, the financial statements, and other financial
information included in this periodic report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this periodic report;

(4) The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

     a) designed such disclosure controls and procedures to ensure that material
     information relating to the registrant, including its consolidated
     subsidiaries, is made known to us by others within those entities,
     particularly during the period in which this periodic report is being
     prepared;

     b) evaluated the effectiveness of the registrant's disclosure controls and
     procedures as of the date within 90 days prior to filing date of this
     periodic report (the "Evaluation Date"); and

     c)presented in this periodic report our conclusions about the effectiveness
     of the disclosure controls and procedures based on our evaluation as of the
     Evaluation Date;

(5) The registrant's other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit committee
of registrant's board of directors (or persons performing the equivalent
function):

     a) all significant deficiencies in the design or operation of internal
     controls which could adversely affect the registrant's ability to record,
     summarize and report financial data and have identified for the
     registrant's auditors any material weaknesses in internal controls; and

     b) any fraud, whether or not material, that involves management or other
     employees who have a significant role in the registrant's internal
     controls; and

(6) The registrant's other certifying officers and I have indicated in this
periodic report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal controls
subsequent to the date of our most recent evaluation, including any corrective
actions with regard to significant deficiencies and material weaknesses.

 Dated: May 11, 2004                        /s/ Michael Kelleher
                                              --------------------
                                                Michael Kelleher
                                                President
Exhibit 10.4

AMENDED AND RESTATED  EMPLOYMENT AGREEMENT

This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this "Agreement") is made and entered into as of the 17 day of September, 2003, by and between FIRST
HORIZON PHARMACEUTICAL CORPORATION, a Delaware corporation (the "Company") and DARRELL BORNE ("Executive").

WITNESSETH:

WHEREAS, Executive is employed by the Company pursuant to the terms and conditions of that certain Employment Agreement dated June 12, 2003 between the
Company and Executive (the "Original Agreement"); and

WHEREAS,
the parties desire to amend and restate the terms and conditions of the Original Agreement, effective as of the date hereof:

NOW,
THEREFORE, in consideration of Executive's employment or continued employment, the covenants and mutual agreements set forth herein and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto do hereby agree as follows:



---



2

---



3

---



4

---



5

---



6

---



7

---





8

---





9

---



IN
WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of the day and year first above written.

| |  | EXECUTIVE:                              
| |  | ----------------------------------------
| |  | /s/ DARRELL BORNEName: Darrell Borne    
| |  | FIRST HORIZON PHARMACEUTICAL CORPORATION
| |  | By:                                     
| |  | Its:                                    

10

---

QuickLinks
##### 



Exhibit 32.2 CERTIFICATION OF THE CFO OF ATARI, INC. PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Atari, Inc. (the Company) on Form 10-K for the
fiscal year ended March 31, 2005, as filed with the Securities and Exchange Commission on the date
hereof (the Report), I, Diane Price Baker, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the
financial condition and result of operations of the Company. By:
    /s/
Diane Price BakerName:
    Diane Price BakerTitle:
    Chief Financial Officer Date: June 14, 2005
Consent of General Counsel is contained in Exhibit 5.1.
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                           06-30-2000
<PERIOD-END>                               SEP-30-1998
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                       0
<CURRENT-LIABILITIES>                           12,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     1,255,142
<OTHER-SE>                                   1,267,142
<TOTAL-LIABILITY-AND-EQUITY>                         0
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                    5,500
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,500)
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>